General Information of the Compound
| Compound ID |
CP0004329
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)benzylamino)-4-oxobutanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H43N9O10
|
||||||||||||||||||
| Molecular Weight |
737.771
|
||||||||||||||||||
| Canonical SMILES |
NC(N)=NCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)c1ccc(CNC(=O)CCC(O)=O)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H43N9O10/c35-34(36)37-14-4-7-22-30(50)39-18-26(45)40-24(16-28(48)49)31(51)42-23(15-19-5-2-1-3-6-19)32(52)43-29(33(53)41-22)21-10-8-20(9-11-21)17-38-25(44)12-13-27(46)47/h1-3,5-6,8-11,22-24,29H,4,7,12-18H2,(H,38,44)(H,39,50)(H,40,45)(H,41,53)(H,42,51)(H,43,52)(H,46,47)(H,48,49)(H4,35,36,37)/t22-,23+,24-,29-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YPBCOKBVZUVWMI-MVPDCNEZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03794, Integrin alpha-V
Cell Viability or Cytotoxicity Assay